上海莱士：11月28日召开董事会会议

Group 1 - The core point of the article is that Shanghai Raist (SZ 002252) held a temporary board meeting on November 28, 2025, to review the proposal for revising the "Audit Committee Working Rules" [1] - For the first half of 2025, the revenue composition of Shanghai Raist was as follows: 99.21% from blood product production and sales, 0.76% from testing equipment and reagents, and 0.03% from other businesses [1] - As of the report date, Shanghai Raist's market capitalization was 44 billion yuan [1]